Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
27
01
2023
accepted:
25
09
2023
medline:
1
11
2023
pubmed:
5
10
2023
entrez:
5
10
2023
Statut:
epublish
Résumé
Colorectal Cancer (CRC) and Obesity constitute two of the most common malignancies in the western world, and previously have been associated with intestinal microbial composition alterations. Our main aim in this study is to provide molecular data on intestinal microbiota patterns in subjects with CRC, as well as to establish possible associations with their Body Mass Index (BMI). A total of 113 samples from 45 subjects were collected and submitted to metagenomics analysis for gut microbiota. This study was performed by 16S ribosomal RNA bacterial gene amplification and sequencing using the Ion Torrent™ technology. The same dominant phyla were observed in feces and colorectal tissues, although a greater proportion of Fusobacteriota was found in tumor samples. Moreover, at the genus level, LEfSe analysis allowed us to detect a significant increase in Fusobacterium and Streptococcus in colorectal tissues with respect to fecal samples, with a significant preponderance of Fusobacterium in tumor tissues. Also, our data revealed relevant associations between gut microbiota composition and tumor location. When comparing bacterial profiles between right and left colon cancers, those from the left-sided colon showed a significant preponderance, among others, of the order Staphylococcales. Moreover, phyla Firmicutes and Spirochaetota were more abundant in the group of right-sided CRCs and phylum Proteobacteria was increased in rectal cancers. In relation to BMI of patients, we detected significant differences in beta diversity between the normal weight and the obese groups of cases. Microbiota from obese patients was significantly enriched, among others, in Bacteroidales. Therefore, our results are useful in the molecular characterization of CRC in obese and non-obese patients, with a clear impact on the establishment of diagnostic and prognosis of CRC.
Identifiants
pubmed: 37796924
doi: 10.1371/journal.pone.0292551
pii: PONE-D-23-02427
pmc: PMC10553240
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0292551Informations de copyright
Copyright: © 2023 Tesolato et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nucleic Acids Res. 1976 Sep;3(9):2303-8
pubmed: 987581
Int J Environ Res Public Health. 2020 Oct 19;17(20):
pubmed: 33086688
Cancer Med. 2019 Feb;8(2):480-491
pubmed: 30636375
Cancer Cell. 2018 Jun 11;33(6):954-964
pubmed: 29657127
PLoS One. 2019 Feb 22;14(2):e0212406
pubmed: 30794590
Cancers (Basel). 2022 Sep 30;14(19):
pubmed: 36230724
Sci Rep. 2022 Jun 14;12(1):9829
pubmed: 35701595
Front Microbiol. 2019 Apr 24;10:826
pubmed: 31068913
Cancers (Basel). 2020 May 29;12(6):
pubmed: 32486076
J Natl Cancer Inst. 2013 Dec 18;105(24):1907-11
pubmed: 24316595
Infect Drug Resist. 2022 Mar 17;15:1115-1120
pubmed: 35321079
mSystems. 2020 Apr 14;5(2):
pubmed: 32291348
J Clin Lab Anal. 2022 May;36(5):e24359
pubmed: 35312122
Nat Commun. 2018 Jul 18;9(1):2802
pubmed: 30022049
World J Gastroenterol. 2021 Jul 7;27(25):3837-3850
pubmed: 34321848
Front Microbiol. 2021 Oct 20;12:705583
pubmed: 34745023
iScience. 2023 Mar 22;26(4):106476
pubmed: 37096041
Nat Med. 2022 Apr;28(4):690-703
pubmed: 35440726
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Front Immunol. 2022 Jan 07;12:807648
pubmed: 35069592
Nat Med. 2019 Apr;25(4):667-678
pubmed: 30936548
Antioxidants (Basel). 2020 Jul 21;9(7):
pubmed: 32708095
Int J Mol Sci. 2017 Jun 20;18(6):
pubmed: 28632155
Clin Gastroenterol Hepatol. 2019 Jan;17(2):275-289
pubmed: 30031175
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18321-6
pubmed: 25489084
Commun Med (Lond). 2022 Oct 7;2:127
pubmed: 36217535
Front Microbiol. 2023 Apr 18;14:1126808
pubmed: 37143538
Arch Med Res. 2022 Jun;53(4):407-415
pubmed: 35382951
Int J Mol Sci. 2021 Oct 04;22(19):
pubmed: 34639088
BMJ. 2017 Feb 28;356:j477
pubmed: 28246088
Nutrients. 2022 Jan 31;14(3):
pubmed: 35276983
J Gastroenterol Hepatol. 2021 Apr;36(4):1035-1043
pubmed: 32633422
BMC Biol. 2019 Oct 28;17(1):83
pubmed: 31660948
Front Immunol. 2020 Nov 30;11:615056
pubmed: 33329610
Eur Surg Res. 2021;62(4):248-254
pubmed: 34198297
Nat Rev Immunol. 2020 Jan;20(1):40-54
pubmed: 31388093